InterCure Income Statement Analysis

Revenue, earnings, and profit margins in millions ILS

Scroll to see more
InterCure Ltd. income statement - Annual data in millions ILS
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue238.85355.55388.68219.6865.04
Cost of Revenue208.61250.46233.60128.5531.45
Gross Profit30.23105.10155.0891.1333.59
Operating Expenses
Research & Development0.410.390.631.241.58
Selling, General & Administrative84.6386.2497.3253.4617.03
Operating Expenses97.4467.50113.8858.1134.79
Operating Income-67.2137.5941.2033.02-1.21
Other Income/Expense
Interest Income2.705.380.840.130.02
Interest Expense22.7924.2214.695.05-0.26
Other Income/Expense-20.12-79.2116.75-9.38-0.26
Income
Income Before Tax-87.32-61.2943.8418.73-38.31
Income Tax Expense-14.532.250.0911.44-2.27
Net Income-67.80-61.9644.824.69-37.23
Net Income - Continuous Operations-67.80-63.5343.757.290.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-51.31-23.9070.2331.172.05
EBIT-87.89-37.0758.5323.78-1.21
Depreciation & Amortization15.377.874.222.933.25
Earnings Per Share
Basic EPS-1.00-1.001.00--1.00
Diluted EPS-1.00-1.001.00--1.00
Basic Shares Outstanding45.5745.8745.3538.4925.40
Diluted Shares Outstanding45.5745.8745.3546.9225.40